Centro Hospitalar do Tâmega e Sousa Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02164825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Centro Hospitalar do Tâmega e Sousa

Active Ingredients

Drugs in Other Trials (2)

morphine (1 trial)

ropivacaine (naropin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2